Page last updated: 2024-10-24

verapamil and Island Cell Tumor

verapamil has been researched along with Island Cell Tumor in 5 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of treatment with either verapamil (V), the long-acting somatostatin analogue octreotide (OCT) alone, and the combined treatment (V + OCT) were studied in a patient with a symptomatic metastasized malignant insulinoma."7.67Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? ( Fischer, HR; Hackeng, WH; Lems, WF; Stehouwer, CD, 1989)
"The efficacy of treatment with either verapamil (V), the long-acting somatostatin analogue octreotide (OCT) alone, and the combined treatment (V + OCT) were studied in a patient with a symptomatic metastasized malignant insulinoma."3.67Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? ( Fischer, HR; Hackeng, WH; Lems, WF; Stehouwer, CD, 1989)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Marinis, L1
Barbarino, A1
Shapiro, S1
Kaneko, Y1
Baum, SG1
Fleischer, N1
Harty, RF1
Jain, DK1
McGuigan, JE1
Stehouwer, CD1
Lems, WF1
Fischer, HR1
Hackeng, WH1
Imanaka, S1
Matsuda, S1
Ito, K1
Matsuoka, T1
Okada, Y1

Other Studies

5 other studies available for verapamil and Island Cell Tumor

ArticleYear
Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.
    Metabolism: clinical and experimental, 1980, Volume: 29, Issue:7

    Topics: Adenoma, Islet Cell; Adolescent; Adult; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Gly

1980
The role of calcium in insulin release from hamster insulinoma cells.
    Endocrinology, 1977, Volume: 101, Issue:2

    Topics: Adenoma, Islet Cell; Animals; Calcium; Cricetinae; Cyclic AMP; Deoxyglucose; Female; Glucagon; Gluco

1977
Mechanisms of vasoactive intestinal peptide release in short-term culture of vasoactive intestinal peptide-producing tumor.
    Gastroenterology, 1988, Volume: 94, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Adenoma, Islet Cell; Calcimycin; Calcium; Cells, Cultured; Cyclic AMP;

1988
Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    The Netherlands journal of medicine, 1989, Volume: 35, Issue:1-2

    Topics: Adenoma, Islet Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Insulinom

1989
Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
    Japanese journal of clinical oncology, 1986, Volume: 16, Issue:1

    Topics: Adenoma, Islet Cell; Aged; Benzazepines; Blood Glucose; C-Peptide; Celiac Artery; Diltiazem; Female;

1986